American International Group, Inc. V Tv Therapeutics Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.27 - $3.44 $15,678 - $23,760	-6,907 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.97 - $2.89 $971 - $1,424	493 Added 7.69%	6,907 $19,000
Q4 2020 Feb 12, 2021	BUY	$1.49 - $3.1 $272 - $567	183 Added 2.94%	6,414 $12,000
Q3 2020 Nov 04, 2020	BUY	$1.7 - $2.98 $499 - $876	294 Added 4.95%	6,231 $11,000
Q2 2020 Aug 12, 2020	BUY	$1.74 - $3.19 $10,330 - $18,939	5,937 New	5,937 $13,000

Q2 2018 Aug 08, 2018	SELL	$0.71 - $4.04 $3,219 - $18,317	-4,534 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$3.91 - $7.83 $954 - $1,910	-244 Reduced 5.11%	4,534 $18,000
Q4 2017 Feb 09, 2018	BUY	$3.9 - $7.77 $89 - $178	23 Added 0.48%	4,778 $29,000
Q3 2017 Nov 09, 2017	BUY	$3.83 - $6.07 $18,211 - $28,862	4,755	4,755 $28,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.